PH11611A - 1-(3-amino-2-hydroxypropoxy)isoquinoline derivatives and pharmaceutical compositions thereof - Google Patents

1-(3-amino-2-hydroxypropoxy)isoquinoline derivatives and pharmaceutical compositions thereof

Info

Publication number
PH11611A
PH11611A PH16382A PH16382A PH11611A PH 11611 A PH11611 A PH 11611A PH 16382 A PH16382 A PH 16382A PH 16382 A PH16382 A PH 16382A PH 11611 A PH11611 A PH 11611A
Authority
PH
Philippines
Prior art keywords
hydroxypropoxy
amino
pharmaceutical compositions
isoquinoline derivatives
isoquinoline
Prior art date
Application number
PH16382A
Other languages
English (en)
Inventor
E Wiskott
F Troxler
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of PH11611A publication Critical patent/PH11611A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH16382A 1973-10-08 1974-10-07 1-(3-amino-2-hydroxypropoxy)isoquinoline derivatives and pharmaceutical compositions thereof PH11611A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1430773A CH581113A5 (fi) 1973-10-08 1973-10-08

Publications (1)

Publication Number Publication Date
PH11611A true PH11611A (en) 1978-04-12

Family

ID=4399720

Family Applications (1)

Application Number Title Priority Date Filing Date
PH16382A PH11611A (en) 1973-10-08 1974-10-07 1-(3-amino-2-hydroxypropoxy)isoquinoline derivatives and pharmaceutical compositions thereof

Country Status (21)

Country Link
JP (1) JPS5082078A (fi)
AT (1) ATA802974A (fi)
AU (2) AU498889B2 (fi)
BE (1) BE820789A (fi)
CA (1) CA1021772A (fi)
CH (1) CH581113A5 (fi)
DD (1) DD114605A5 (fi)
DE (1) DE2447756A1 (fi)
DK (1) DK135766B (fi)
ES (1) ES430759A1 (fi)
FI (1) FI286374A (fi)
FR (1) FR2247242B1 (fi)
GB (1) GB1474775A (fi)
HU (1) HU169126B (fi)
IL (1) IL45797A (fi)
NL (1) NL7413105A (fi)
NO (1) NO743534L (fi)
PH (1) PH11611A (fi)
SE (1) SE7412310L (fi)
SU (1) SU567403A3 (fi)
ZA (1) ZA746409B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK116976A (da) * 1975-03-26 1976-09-27 Sandoz Ag Fremgangsmade til fremstilling af isoquinolinderivater
US4129565A (en) * 1975-07-11 1978-12-12 Nisshin Flour Milling Co., Ltd. Isocarbostyril derivatives
SE7804318L (sv) * 1977-05-02 1978-11-03 Merck & Co Inc Nya naftyridiner
EP0711804A3 (de) 1994-11-14 1999-09-22 Ciba SC Holding AG Kryptolichtschutzmittel
US6426415B1 (en) 1997-09-03 2002-07-30 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
US6346536B1 (en) 1997-09-03 2002-02-12 Guilford Pharmaceuticals Inc. Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same
US6291425B1 (en) 1999-09-01 2001-09-18 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US6514983B1 (en) 1997-09-03 2003-02-04 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6197785B1 (en) * 1997-09-03 2001-03-06 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
US6635642B1 (en) 1997-09-03 2003-10-21 Guilford Pharmaceuticals Inc. PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
US6395749B1 (en) 1998-05-15 2002-05-28 Guilford Pharmaceuticals Inc. Carboxamide compounds, methods, and compositions for inhibiting PARP activity
US6387902B1 (en) 1998-12-31 2002-05-14 Guilford Pharmaceuticals, Inc. Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
AU2001264595A1 (en) 2000-05-19 2001-12-03 Guilford Pharmaceuticals Inc. Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses
US6348475B1 (en) 2000-06-01 2002-02-19 Guilford Pharmaceuticals Inc. Methods, compounds and compositions for treating gout

Also Published As

Publication number Publication date
IL45797A0 (en) 1974-12-31
AU7409074A (en) 1976-04-15
AU7413074A (en) 1976-04-15
NL7413105A (nl) 1975-04-10
CA1021772A (en) 1977-11-29
SU567403A3 (ru) 1977-07-30
CH581113A5 (fi) 1976-10-29
HU169126B (fi) 1976-09-28
FR2247242B1 (fi) 1978-07-21
DD114605A5 (fi) 1975-08-12
AU7408974A (en) 1976-04-15
DE2447756A1 (de) 1975-04-10
BE820789A (fr) 1975-04-07
FR2247242A1 (fi) 1975-05-09
AU498889B2 (en) 1979-03-29
NO743534L (fi) 1975-05-05
FI286374A (fi) 1975-04-09
IL45797A (en) 1978-04-30
DK514874A (fi) 1975-06-09
ES430759A1 (es) 1977-04-16
ATA802974A (de) 1979-07-15
DK135766B (da) 1977-06-20
SE7412310L (fi) 1975-04-09
JPS5082078A (fi) 1975-07-03
ZA746409B (en) 1976-05-26
DK135766C (fi) 1977-11-21
GB1474775A (en) 1977-05-25

Similar Documents

Publication Publication Date Title
PH10519A (en) 4-hydroxymethyl-1-phthalazone derivatives and pharmaceutical compositions thereof
PH10649A (en) Sulphoxide derivatives and pharmaceutical compositions thereof
IL44795A0 (en) Pharmaceutical compositions containing arylthioalkanols and novel arylthioalkanols
NZ180529A (en) Erythromyc-9-yl-amine derivatives and pharmaceutical compositions
GB1482552A (en) Benzomorphanes and morphinane derivatives and pharmaceutical compositions containing the same
PH11611A (en) 1-(3-amino-2-hydroxypropoxy)isoquinoline derivatives and pharmaceutical compositions thereof
IL50869A0 (en) Novel imidazole derivatives their preparation and pharmaceutical compositions containing them
NZ181009A (en) Heteroaryl derivatives and pharmaceutical compositions
GB1537880A (en) 1-triarylalkyl-4-phenyl-4-piperidine-methanols and derivatives and pharmaceutical compositions containing them
PH12944A (en) Pyrazole derivatives and their pharmaceutical composition
IL45609A0 (en) New isoquinoline derivatives,their preparation and pharmaceutical compositions containing them
GB1483343A (en) Derivatives of amitriptyline and pharmaceutical uses thereof
IL48508A (en) Pharmaceutical compositions comprising piperidylindole derivatives
IL44794A0 (en) Pharmaceutical compositions containing certain triazolyl derivatives
IL50230A0 (en) Novel imidazole derivatives their preparation and pharmaceutical compositions containing them
IL43766A0 (en) Pharmaceutical compositions containing bis-phenolalkane derivatives
ZA742956B (en) Pharmaceutical compositions containing triazolo-isoquinoline derivatives
PH10643A (en) Benzylpyrimidine derivatives and pharmaceutical compositions thereof
NZ182161A (en) Alkoxy-pyridine-carobxamide derivatives and pharmaceutical compositions
PH11231A (en) Piperidinesulfonylurea derivatives and pharmaceutical compositions containing them
NZ181727A (en) Pyrroline-2-one derivatives and pharmaceutical compositions
IL47155A0 (en) New isoquinoline derivatives,their preparation and pharmaceutical compositions containing them
IL45950A (en) 2-glycylamido-4-pyridyl-thiazole derivatives their preparation and pharmaceutical compositions containing them
IE39291B1 (en) Pharmaceutical compositions comprising an anzyme and substtrate
NZ181401A (en) 2-benzopyranone derivatives and pharmaceutical compositions